🇺🇸 FDA
Pipeline program

XPF-010, XPF-008, XEN1101 placebo

XPF-008-201

Phase 2 small_molecule active

Quick answer

XPF-010, XPF-008, XEN1101 placebo for Adult focal (partial onset) epilepsy is a Phase 2 program (small_molecule) at Xenon Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Xenon Pharmaceuticals
Indication
Adult focal (partial onset) epilepsy
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials